Cargando…
Targeting Prostate Cancer, the ‘Tousled Way’
Androgen deprivation therapy (ADT) has been the mainstay of prostate cancer (PCa) treatment, with success in developing more effective inhibitors of androgen synthesis and antiandrogens in clinical practice. However, hormone deprivation and AR ablation have caused an increase in ADT-insensitive PCas...
Autores principales: | Bhoir, Siddhant, Benedetti, Arrigo De |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341820/ https://www.ncbi.nlm.nih.gov/pubmed/37446279 http://dx.doi.org/10.3390/ijms241311100 |
Ejemplares similares
-
The Tousled-Like Kinases as Guardians of Genome Integrity
por: De Benedetti, Arrigo
Publicado: (2012) -
High yield bacterial expression, purification and characterisation of bioactive Human Tousled-like Kinase 1B involved in cancer
por: Bhoir, Siddhant, et al.
Publicado: (2018) -
Untousling the Role of Tousled-like Kinase 1 in DNA Damage Repair
por: Ghosh, Ishita, et al.
Publicado: (2023) -
Exploiting TLK1 and Cisplatin Synergy for Synthetic Lethality in Androgen-Insensitive Prostate Cancer
por: Bhoir, Siddhant, et al.
Publicado: (2023) -
Tousled-like kinase 1: a novel factor with multifaceted role in mCRPC progression and development of therapy resistance
por: Khalil, Md Imtiaz, et al.
Publicado: (2022)